Displaying drugs 351 - 375 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Benralizumab | 146054.0 C6492H10060N1724O2028S42 |  | A monoclonal antibody used to treat eosinophilic asthma. | Anti-Asthmatic Agents / Interleukin-5 Receptor alpha-directed Cytolytic Antibody |
| Belimumab | 147000.0 C6358H9904N1728O2010S44 |  | A B-lymphocyte stimulator (BLyS)-specific inhibitor used to treat systemic lupus erythematosus and active lupus nephritis as an add-on therapy. | Selective Immunosuppressants |
| Belatacept | 92300.0 C3508H5440N922O1096S32 |  | A selective T-cell costimulation blocker used in the prophylaxis of organ rejection in adult patients receiving a kidney transplant. | Selective Immunosuppressants |
| Belantamab mafodotin | Not Available | | An anti B-cell maturation antigen antibody conjugated to a microtubule inhibitor to treat relapsed or refractory multiple myeloma. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antibody-drug Conjugates / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Blood Proteins / BSEP/ABCB11 Substrates / Cancer immunotherapy / Globulins / Immunoglobulins / Immunoproteins / Immunotherapy / MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES / OATP1B1/SLCO1B1 Substrates / OATP1B3 substrates / P-glycoprotein substrates / Proteins / Serum Globulins / Tubulin Inhibiting Agent |
| Becaplermin | 12294.4 C532H892N162O153S9 |  | A recombinant form of human platelet-derived growth factor used to treat ulcers due to diabetic neuropathy in the lower extremities when there is adequate blood supply to the area. | Angiogenesis Inducing Agents / DNA-Binding Proteins / Human Platelet-derived Growth Factor / Platelet-Derived Growth Factor / Proto-Oncogene Proteins / Proto-Oncogene Proteins c-sis |
| Basiliximab | 143801.3 C6378H9844N1698O1997S48 |  | A monoclonal anti-C25 antibody (interleukin-2 receptor alpha subunit) used as immunosuppressive therapy in kidney transplant patients. | Interleukin Inhibitors |
| Bamlanivimab | 146000.0 C6498H10068N1732O2032S46 | | A neutralizing human IgG1κ monoclonal antibody against the SARS-CoV-2 spike (S) protein for use in patients aged 12 and over at high risk of developing severe COVID-19. | Antiviral Agents |
| Avelumab | 147000.0 C6374H9898N1694O2010S44 | | An anti-PD-L1 monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma. | Antibodies, Monoclonal / PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Avalglucosidase alfa | 124000.0 C4490H6818N1197O1299S32 | | A lysosomal glycogen-specific enzyme that is used to treat patients one year of age and older with late-onset Pompe disease, or lysosomal acid alpha-glucosidase (GAA) deficiency. | Enzymes |
| Atoltivimab | 145097.54 C6448H9954N1726O2002S44 | | Part of a product containing three monoclonal IgG1κ antibodies directed against the GP1,2 glycoprotein of Zaire ebolavirus. Together, these three antibodies act to neutralize viral particles and to recruit immune effectors for the destruction of both viral particles and infected cells. | Antiviral Agents |
| Atezolizumab | 145000.0 | | A monoclonal antibody used to treat advanced or metastatic urothelial carcinoma with disease progression during or up to 12 months after platinum-containing chemotherapy. | Antibodies, Monoclonal / PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Asparaginase Escherichia coli | C1377H2208N382O442S17 |  | An asparaginase enzyme from E. coli used as part of treatment regimens for acute lymphoblastic leukemias. | Amidohydrolases / Asparagine-specific Enzyme |
| Asparaginase Erwinia chrysanthemi | 140000.0 C1546H2510N432O476S9 |  | An asparagine-specific enzyme used as part of a chemotherapeutic regimen to treat patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. | Amidohydrolases / Antineoplastic Agents / Asparagine-specific Enzyme |
| Asfotase alfa | 180000.0 C7108H11008N1968O2206S56 |  | An enzyme replacement therapy used for the treatment of perinatal/infantile and juvenile onset hypophosphatasia (HPP). | Enzyme Replacement Therapy / Enzymes / Tissue-nonspecific Alkaline Phosphatase |
| Aprotinin | 6511.439 C284H432N84O79S7 |  | A serine protease inhibitor used to reduce the risk for perioperative blood loss and the need for blood transfusion in high-risk patients during cardiopulmonary bypass for coronary artery bypass graft surgery. | Proteinase Inhibitors |
| Apadamtase alfa | Not Available | | A recombinant human ADAMTS13 for enzyme replacement therapy in patients with congenital thrombotic thrombocytopenic purpura. | Recombinant Proteins |
| Antithymocyte immunoglobulin (rabbit) | Not Annotated |  | A purified form of rabbit anti-thymocyte antibodies used for immunosuppression in patients receiving kidney transplants. | Selective Immunosuppressants |
| Antithrombin III human | Not Available | | An alpha-2-glycoprotein used to prevent thromboembolisms in patients with hereditary antithrombin III deficiency. | Alpha-Globulins / Antithrombin III / Antithrombin III, agonists / Antithrombin Proteins / Blood Coagulation Factor Inhibitors |
| Antithrombin Alfa | Not Available | | A recombinant antithrombin used to treat peri-operative and peripartum thromboembolic events in hereditary antithrombin deficiency. | Recombinant Antithrombin |
| Antilymphocyte immunoglobulin (horse) | Not Available | | A primarily IgG immune globulin used to manage allograft rejection in renal transplant patients. | Selective Immunosuppressants |
| Antihemophilic factor, human recombinant | 264725.5 C11794H18314N3220O3553S83 |  | A form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency. | Blood Coagulation Factors |
| Antihemophilic factor human | 480000.0 |  | A Factor VIII replacement therapy used to treat hemophilia A. | Blood Coagulation Factors |
| Antihemophilic factor (recombinant), PEGylated | 284.0 | | For the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)... | Recombinant Proteins |
| Anti-inhibitor coagulant complex | Not Available | | A medication used to control bleeding episodes and prevent bleeding episodes in hemophilia A and B. | Blood Coagulation Factors |
| Anthrax immune globulin human | Not Available | | An immunizing agent used for the treatment of inhalational anthrax in adult and pediatric patients in combination with antibacterial agents. | Amino Acids, Peptides, and Proteins / Blood Proteins / Human Immunoglobulin / Immunoglobulins / Proteins / Serum / Serum Globulins / Vaccines |
Displaying drugs 351 - 375 of 406 in total